pre-IPO PHARMA

COMPANY OVERVIEW

ArunA Bio is harnessing the natural abilities of neural exosomes to cross the blood brain barrier and enhance the body’s anti-inflammatory, self-repair and protective mechanisms to treat a range of neurodegenerative disorders. ArunA Bio is also leveraging its proprietary exosomes and manufacturing platform to create synergistic therapies by enhancing exosomes with RNA, oligonucleotides, antibodies and small molecules.


LOCATION

  • Athens, GA, USA

  • THERAPEUTIC AREAS

  • Cardiovascular Disease
  • Inflammatory DIsease
  • Neurological DIsorders

  • WEBSITE

    https://arunabio.com


    CAREER WEBSITE

    https://arunabio.com/careers


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Oct 6, 2022

    Aruna Bio Announces Presentation on Neural Exosome Treatment Opportunities and Lead Program, AB126 at Exosome Based Therapeutic Development Summit


    May 31, 2022

    Aruna Bio Advances Therapeutic Development for Traumatic Brain Injury


    Sep 23, 2021

    Aruna Bio Appoints John Richard to Board of Directors


    Apr 14, 2021

    Aruna Bio Closes $10.8 Million Common Stock Financing


    Dec 4, 2019

    Aruna Bio Appoints Dr. James Paskavitz as Vice President of Research and Development


    For More Press Releases


    Google Analytics Alternative